Table 4.

Clinical parameters in PH patients versus matched pediatric RRT population

DialysisTransplantation
PH PatientsNon-PH PatientsPH PatientsNon-PH Patients
Height, mean SD score −1.5 (−2.9 to −0.1)−1.4 (−2.1 to −0.7)−1.3 (−2.0 to −0.6)−1.4 (−1.7 to −1.1)
Laboratory values
 hemoglobin (g/dl), mean9.4 (8.8–10.0)a10.4 (10.1–10.7)11.7 (11.0–12.4)12.0 (11.7–12.3)
 parathyroid hormone (pg/ml), median 438 (184–711)417 (214–621)122 (59–303)174 (124–224)
 albumin (g/L), mean 32.1 (29.4–34.9)a36.0 (34.9–37.2)39.4 (37.0–41.9)42.4 (40.2–44.5)
BP
 % hypertensive59583950
 systolic BP, mean SD score 1.4 (0.7–2.2)1.3 (1.1–1.5)0.8 (0.3–1.3)1.0 (0.8–1.2)
 diastolic BP, mean SD score1.4 (1.0–1.8)1.2 (1.0–1.4)0.7 (0.3–1.0)0.8 (0.6–0.9)
  • Data in parentheses are 95% confidence intervals. PH, primary hyperoxaluria; RRT, renal replacement therapy;

  • a Significantly lower in PH patients than in non-PH patients (P<0.05).